Cardiovascular Disease· Topic 2.3 Ischemic heart disease· 2.3.3

Acute coronary syndrome: an overview

Acute coronary syndrome is the umbrella term for unstable angina, NSTEMI, and STEMI, all arising from plaque rupture or erosion; the presenting ECG and troponin split the spectrum and set the initial recognition, risk-stratification, and treatment pathway before it branches into disease-specific management.

9 min read9 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Acute coronary syndrome (ACS) is an umbrella term, not one diagnosis: it covers unstable angina, NSTEMI, and STEMI, all resulting from acute or subacute coronary plaque rupture or erosion with…

  • Epidemiology

    Cardiovascular disease is the leading cause of death in the United States, and in women specifically causes more deaths than cancer, diabetes, and kidney disease combined, despite a 22% decline in…

  • Risk factors

    Traditional atherosclerotic risk factors: hypertension, diabetes mellitus, hyperlipidemia, current smoking, and abdominal obesity.

  • Pathophysiology

    Type 1 MI (atherothrombotic): plaque rupture or erosion exposes thrombogenic material, triggering platelet adhesion, activation, and aggregation and acute thrombotic occlusion.

  • Clinical features

    Chest pain or an anginal equivalent at rest or with minimal exertion, often intense substernal pressure or crushing pain radiating to the neck, jaw, arms, or back; a new or worsening pattern distinguishes ACS from stable angina.

  • Differential diagnosis

    Acute aortic dissection: tearing pain radiating to the back, a blood pressure or pulse differential between the arms, and mediastinal widening on chest radiograph; matters most because thrombolytics…

  • Diagnosis

    The diagnosis is established by the ECG and cardiac troponin, not a single confirmatory test: ST elevation of at least 1 mm in two or more contiguous leads (at least 2 mm in V2-V3 in men, 1.5 mm in…

  • Management

    First, for every ACS presentation: continuous ECG monitoring, IV access, and aspirin 162-325 mg PO (non-enteric, chewed) at presentation, then 81 mg PO daily indefinitely.

  • Complications

    Cardiogenic shock, the most severe complication, carries 50% to 80% mortality; typically follows a large anterior MI with severely reduced LV function, suggested by hypotension, oliguria, and cool extremities.

  • Prognosis

    Time to reperfusion is the dominant driver of outcome: a shorter time improves outcomes regardless of whether primary PCI or fibrinolysis is used.

  • Prevention

    Continue secondary-prevention medications indefinitely after ACS: aspirin 81 mg PO daily for life; dual antiplatelet therapy at least 12 months, extended beyond 1 year in high-thrombotic-risk…

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.